Form 4: Heartflow Executive Reports Stock, Option Grants

Heartflow's Chief Accounting Officer, Marie L. Jones, reported the acquisition of restricted stock units and stock options, alongside a disposition of shares for tax obligations.

Summary

• Marie L. Jones, Chief Accounting Officer and VP of Heartflow, Inc. (HTFL), reported transactions on February 6, 2026.
• Disposed of 94 shares of common stock at $27.74 per share to cover income tax withholding related to previously vested restricted stock units.
• Acquired 21,629 restricted stock units (RSUs) with a vesting commencement date of February 6, 2026. These RSUs will vest 1/16th on each quarterly anniversary of the commencement date, subject to continued service.
• Acquired 37,795 stock options with an exercise price of $27.74. These options vest 1/48th on each monthly anniversary of the vesting commencement date (February 6, 2026), subject to continued service, and expire on February 6, 2036.
• Following these transactions, Marie L. Jones beneficially owns 31,650 shares of common stock and 37,795 stock options.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive signal, reflecting standard executive compensation practices designed to align management incentives with long-term shareholder value, without indicating any immediate operational changes.

Positives

• Grant of 21,629 Restricted Stock Units (RSUs) to a key executive, aligning management incentives with shareholder value.
• Grant of 37,795 stock options with an exercise price of $27.74, providing long-term incentive for the executive.

Negatives

• Disposition of 94 shares of common stock, though for tax purposes, represents a minor reduction in direct ownership.

Future Outlook

The grants indicate a long-term incentive structure for the executive, with vesting schedules extending into the future, implying continued service and alignment with future company performance.

Industry Context

StockSavvy.ai notes that executive compensation packages frequently include a mix of restricted stock units and stock options to incentivize long-term performance and retention, a common practice in the medical technology and healthcare sectors to align executive interests with company growth and innovation.

Comparison to Industry Standards

• Executive compensation structures involving RSUs and stock options are standard across the technology and healthcare industries.
• For example, companies like Medtronic or Intuitive Surgical often utilize similar equity-based incentives to retain top talent and drive innovation, with vesting schedules typically ranging from 3 to 5 years.
• The vesting schedule for Heartflow's RSUs (quarterly over 4 years) and options (monthly over 4 years) is consistent with industry norms designed to encourage sustained performance.

Stakeholder Impact

• Shareholders: Alignment of executive incentives with long-term company performance through equity grants.
• Employees: Standard executive compensation practices may set a precedent or reflect overall compensation philosophy.

Next Steps

• Continued vesting of 21,629 Restricted Stock Units on a quarterly basis, subject to continued service.
• Continued vesting of 37,795 Stock Options on a monthly basis, subject to continued service.

Key Dates

Recommendation

The Form 4 details routine equity grants and a tax-related disposition for a key executive. While these grants align executive incentives with long-term company performance, they do not provide new fundamental information to warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate, pending further operational or financial updates.

Keywords

Heartflow, HTFL, Form 4, Insider Trading, Restricted Stock Units, Stock Options, Executive Compensation, Marie L. Jones, Chief Accounting Officer